Scarica l'app Stockscreener
0.77
11.97%
0.0823
Pre-mercato:
.70
-0.07
-9.09%
Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie
Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World
Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada
Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks
Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Matinas Biopharma (NYSE:MTNB) Shares Down 2.6% – Here’s What Happened - Defense World
MTNB stock touches 52-week low at $0.48 amid sharp annual decline - Investing.com Australia
MTNB stock touches 52-week low at $0.48 amid sharp annual decline By Investing.com - Investing.com South Africa
Matinas BioPharma secures shareholder nods on key proposals By Investing.com - Investing.com Australia
Matinas BioPharma secures shareholder nods on key proposals - Investing.com
Matinas Biopharma Delays 10-K Filing - TipRanks
Matinas Biopharma (NYSE:MTNB) Shares Down 6.6% – Should You Sell? - Defense World
Matinas BioPharma Chairman Eric Ende Resigns -March 17, 2025 at 05:08 am EDT - MarketScreener
Matinas BioPharma announces board chairman’s departure By Investing.com - Investing.com Australia
Matinas BioPharma announces board chairman’s departure - Investing.com
Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma -March 14, 2025 at 05:48 pm EDT - Marketscreener.com
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Silicon Valley - Financial Content
Matinas Biopharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market SessionArtiva Biotherapeutics (NASDAQ:ARTV) - Benzinga
Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors - Marketscreener.com
Matinas BioPharma Announces Agreement for the Acquisition - GlobeNewswire
Biotech Deal Alert: Matinas BioPharma Lands Critical $3.3M Investment While Strengthening Leadership - StockTitan
Matinas BioPharma announces board member retirement - MSN
Matinas BioPharma announces board member retirement By Investing.com - Investing.com South Africa
Matinas BioPharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Matinas Biopharma Appoints Evelyn D’An as Director and Audit Committee Chair - Armenian Reporter
Matinas BioPharma Appoints Evelyn D’An to Board - citybiz
Matinas BioPharma Holdings, Inc. Appoints Evelyn D?An to Board of Directors as an Independent Director and Chair of the Audit Committee - Marketscreener.com
Matinas Biopharma Appoints Evelyn D'An To Board Of Directors As Audit Committee Chair - Marketscreener.com
Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - The Manila Times
Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair - GlobeNewswire
Matinas BioPharma announces board member resignation - MSN
Matinas BioPharma announces board member resignation By Investing.com - Investing.com South Africa
Matinas Biopharma Holdings, Inc. Announces Resignation of James S. Scibetta from Board and Audit and Compensation Committees - Marketscreener.com
111 Equity Group Increases Stake In Matinas Biopharma Holdings - citybiz
111 Equity ups stake in Matinas Biopharma Holdings - Investing.com
Activist Investor 111 Equity Takes 5.17% Stake in Matinas BioPharma, Seeks Value Creation - StockTitan
2.17%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):